Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Division of Molecular thoracic Oncology

Prof. Dr. Rocio Sotillo

Club-originated lung adenocarcinomas lose their identity to become AT2-like cells.
© dkfz.de

Lung cancer is the leading cause of cancer-related deaths worldwide. During the evolution of the cancer genome, additional alterations are acquired, which often accelerate tumour growth. These alterations are translated into unique gene expression profiles that determine the malignant phenotype, including aggressiveness and therapeutic response. We employ state-of-the-art genetically engineered mouse models to understand lung cancer development considering different oncogenic drivers and genomic alterations and aim to also uncover potential markers of poor therapeutic responses.

By integrating lineage tracing mouse models, CRISPR/Cas9 technology, unbiased epigenome and single-cell transcriptome methods, we have mapped the evolutionary pathways of the cells that originate Eml4-Alk rearranged lung tumours. We focus on deciphering a comprehensive molecular characterization of Eml4-Alk driven lung adenocarcinomas and to develop new biomarkers using functional perturbations in autochthonous mouse models.

Our group has also a long-standing interest in cancer aneuploidy and chromosomal instability (CIN). Using a CIN mouse model of breast cancer, we have recently demonstrated that CIN is a mechanism to circumvent oncogene addiction. Further, we have developed and adopted innovative mouse models of human breast and lung cancer to study each step of these phenomena. These models provide a suitable setting to look at the molecular mechanisms and the influence of the immune system that orchestrates genetic instability and tumour heterogeneity as cardinal characteristics of human cancer.

Our lab has also a strong interest in the development of novel mouse models to better understand how cytosine deaminases are involved in human cancer. Our research will leverage unique systems empowering the performance of translational therapeutic studies.

To further strengthen our team we are constantly looking for talented scientists (Master students, PhD students, postdocs). In case of interest you can contact us directly (with your CV and a motivation letter).

Contact

Prof. Dr. Rocio Sotillo
Molecular thoracic Oncology (B220)
Deutsches Krebsforschungszentrum
Im Neuenheimer Feld 280
69120 Heidelberg
Tel: +49 6221 423691

Selected Publications

  • Chen, Y., Toth, R., Chocarro, S., Weichenhan, D., Hey, J., Lutsik, P., Sawall, S., Stathopoulos, G. T., Plass, C., & Sotillo, R. (2022). Club cells employ regeneration mechanisms during lung tumorigenesis. Nature Communications, 13(1), 4557.
  • Salgueiro, L., Buccitelli, C., Rowald, K., Somogyi, K., Kandala, S., Korbel, J. O., & Sotillo, R. (2020). Acquisition of chromosome instability is a mechanism to evade oncogene addiction. EMBO Molecular Medicine, e10941.
  • Carcer, G. de, Venkateswaran, S. V., Salgueiro, L., Bakkali, A. E., Somogyi, K., Rowald, K., Montañés, P., Sanclemente, M., Escobar, B., Martino, A. de, McGranahan, N., Malumbres, M., & Sotillo, R. (2018). Plk1 overexpression induces chromosomal instability and suppresses tumor development.Nature Communications, 9(1), 3012.
  • 2023-03-02 13:11:38
to top
powered by webEdition CMS